Remove 2019 Remove Kidney Disease Remove Myocardial Infarction
article thumbnail

Trends in prognosis and use of SGLT2i and GLP-1 RA in patients with diabetes and coronary artery disease

Cardiovascular Diabetology

Data on major cardiovascular events (MACE; mortality, myocardial infarction, stroke, heart failure) through December 2021 were obtained from national registries. Results Among all patients (n = 38,671), 31% had stable CAD, and 69% suffered an acute myocardial infarction. vs. 6.8%), myocardial infarction (7.7%

article thumbnail

National A-Fib Numbers Higher Than Previously Thought

DAIC

Need for Better Prevention and Treatment UCSF investigators reviewed the medical records of nearly 30 million adult patients who received some form of acute or procedural care in California from 2005 to 2019. percent of the patients treated between 2005 and 2009 to 6.82% of the patients treated between 2015 and 2019. million.

article thumbnail

National A-Fib Numbers Higher Than Previously Tought

DAIC

Need for Better Prevention and Treatment UCSF investigators reviewed the medical records of nearly 30 million adult patients who received some form of acute or procedural care in California from 2005 to 2019. percent of the patients treated between 2005 and 2009 to 6.82% of the patients treated between 2015 and 2019. million.

article thumbnail

Lowering Atherosclerotic Cardiovascular Disease Events by Treating Residual Inflammatory Risk

DAIC

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3

article thumbnail

Predicting survival in patients with severe heart failure: Risk score validation in the HELP‐HF cohort

European Journal of Heart Failure

Recursive feature elimination was employed to identify the most relevant features in predicting the risk of mortality. Abstract Aims Accurate selection of patients with severe heart failure (HF) who might benefit from advanced therapies is crucial.

article thumbnail

Expert Perspective: The Obesity Paradox with Salvatore Carbone, PhD

Cardiometabolic Health Congress

It is for this reason that the 2019 ACC/ AHA guidelines for primary CVD prevention encourage referrals of patients to clinicians and professionals that specialize in lifestyle medicine and can adequately address nutrition and physical activity, such as dietitians, whose role to improve cardiovascular health is too often underestimated. [16]

Obesity 52
article thumbnail

ACC/AHA Release Updated 2023 Guidelines for Atrial Fibrillation

Cardiometabolic Health Congress

These new guidelines provide necessary updates to both the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation and the 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation.